For citations:

Lebedev D.A., Babenko A.Yu., Laevskaya M.Yu., Mosikian A.A., Vasilieva E.Yu., Shlyakhto E.V. Comparable effect of empagliflozin and dapagliflozin therapy on the dynamics of markers of hepatic fibrosis at patients with type 2 diabetes mellitus. Experimental and Clinical Gastroenterology. 2019;(8):16-22. (In Russ.) https://doi.org/10.31146/1682-8658-ecg-168-8-16-22